NIOX Group Plc (LON:NIOX - Get Free Report) was down 3.3% during trading on Tuesday . The company traded as low as GBX 69.40 ($0.93) and last traded at GBX 69.60 ($0.93). Approximately 604,782 shares changed hands during trading, a decline of 43% from the average daily volume of 1,053,004 shares. The stock had previously closed at GBX 72 ($0.96).
NIOX Group Stock Performance
The stock has a market capitalization of £300.87 million, a P/E ratio of 57.60 and a beta of 0.92. The firm has a 50-day moving average of GBX 72.30 and a 200 day moving average of GBX 68.66. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.
NIOX Group (LON:NIOX - Get Free Report) last posted its quarterly earnings data on Tuesday, September 30th. The company reported GBX 1.43 EPS for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. Research analysts anticipate that NIOX Group Plc will post 1.1658256 EPS for the current fiscal year.
NIOX Group Company Profile
(
Get Free Report)
NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.
Headquartered in the UK and listed on the London Stock Exchange ticker: NIOX, the company operates internationally, serving healthcare professionals in over 50 countries.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NIOX Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIOX Group wasn't on the list.
While NIOX Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
